| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 04/06/2000 | WO2000018888A1 Immunomodulation by genetic modification of dendritic cells and b-cells |
| 04/06/2000 | WO2000018885A1 Methods of controlling proliferation and differentiation of stem and progenitor cells |
| 04/06/2000 | WO2000018437A1 Tie2 antagonist antibodies |
| 04/06/2000 | WO2000018427A1 Methods of treating diseased cells |
| 04/06/2000 | WO2000018414A1 Transplantation of neural cells for the treatment of ischemic damage due to stroke |
| 04/06/2000 | WO2000018413A1 Transplantation of neural cells for the treatment of chronic pain or spasticity |
| 04/06/2000 | WO2000018412A1 Solid phase quenching systems |
| 04/06/2000 | WO2000018239A1 Reversibly immortalized hepatocytes and methods of use |
| 04/06/2000 | WO2000018231A1 Methods for treating or preventing viral infections and associated diseases |
| 04/06/2000 | WO1999061468A3 The induction of antibiotic peptides by lait (scd14) protein |
| 04/06/2000 | WO1999058042A3 Specially devised neuronal implants for reconstruction of damaged central nervous system |
| 04/06/2000 | WO1999046657A3 Systems and methods for storing, retrieving, and manipulating data in medical processing devices |
| 04/06/2000 | CA2345347A1 Methods for treating or preventing viral infections and associated diseases |
| 04/06/2000 | CA2345230A1 Methods to selectively inactivate viruses in biological compositions |
| 04/06/2000 | CA2345156A1 Solid phase quenching systems |
| 04/06/2000 | CA2344653A1 Methods of controlling proliferation and differentiation of stem and progenitor cells |
| 04/06/2000 | CA2344622A1 Moraxella catarrhalis protein, nucleic acid sequence and uses thereof |
| 04/06/2000 | CA2344104A1 Method of screening for large offspring syndrome |
| 04/06/2000 | CA2343922A1 Use of specific hybrid promoters for controlling tissue expression |
| 04/05/2000 | EP0990041A1 Regulation of transcription in mammalian cells and viral replication by a tetracyclin repressor |
| 04/05/2000 | EP0990024A1 USE OF $i(LACTOBACILLUS) FOR REDUCTION OF THE FIBRINOGEN LEVEL IN BLOOD |
| 04/05/2000 | EP0990001A1 Processes for production of immunoglobulin a in milk |
| 04/05/2000 | EP0989863A2 System for the in vivo delivery and expression of heterologous genes in the bone marrow |
| 04/05/2000 | EP0989856A1 Method and substances for releasing a growth factor from endothelial cells, growth factor released in accordance with said method and use of same |
| 04/05/2000 | EP0989855A1 Osteoarthritis cartilage regeneration using human mesenchymal stem cells |
| 04/05/2000 | EP0989854A1 Compositions useful as fibrin sealants |
| 04/05/2000 | EP0777740B1 Genetic therapy of diseases of the central nervous system with a cell-specific active substance which is dependent on the cell cycle |
| 04/05/2000 | EP0777739B1 Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle |
| 04/05/2000 | CN1249780A CASH (caspase homologue) with death effector domain, modulators of function of FAS receptors |
| 04/05/2000 | CN1249192A Chinese medicine for treating gout |
| 04/05/2000 | CN1249188A Medicine for treating leukemia and its preparing process |
| 04/05/2000 | CN1249187A Medicine for treating leukemia and its preparing process |
| 04/05/2000 | CN1249183A Medicine for treating chronic trachitis and bronchitis and its preparing process |
| 04/05/2000 | CN1249179A Liquid medicine for treating gastrosis and its preparing process |
| 04/05/2000 | CN1051110C Method and related reagent box for sieve examination of leukemia and its tissue |
| 04/05/2000 | CN1051020C Method for preparing venin cream |
| 04/05/2000 | CN1051019C Stasis eliminating and pulse-beat invigorating capsule |
| 04/05/2000 | CN1051017C Thrombus dissolving 'Guiluchun' |
| 04/05/2000 | CN1051012C Natural medicinal pain dispelling bag |
| 04/05/2000 | CN1051010C Medicine for treating diabetes and complication eye disease, and its preparation method |
| 04/05/2000 | CN1051008C Chinese medicine composition for treatment of coronary heart disease and angina |
| 04/05/2000 | CN1051002C Chinese medicinal herbs composition for treating pulmonary tuberculosis with cavity |
| 04/05/2000 | CN1051000C Health-care product capable of reducing fat |
| 04/05/2000 | CN1050999C Silkworm medicine for resisting viral silkworm diseases |
| 04/05/2000 | CN1050997C Medicinal liquid for treating orthopedic pertinacious disease |
| 04/04/2000 | US6046318 Isolated cdna which encodes a protein having one or more cysteine containing domains; for diagnosis, therapy, recombinant production, and as probes to isolate related proteins in other species and organisms |
| 04/04/2000 | US6046241 Administering to a mammal beta-alethine, or salt, to treat the non-hematolymphoid neoplasia |
| 04/04/2000 | US6046022 Methods and compositions employing red rice fermentation products |
| 04/04/2000 | US6045999 Transcription factor E2F-4 |
| 04/04/2000 | US6045997 Materials and methods relating to the identification and sequencing of the BRCA2 cancer susceptibility gene and uses thereof |
| 04/04/2000 | US6045831 Nuclear inhibitor I-92 and its use for the production of a medicament |
| 04/04/2000 | US6045807 Method for production of neuroblasts |
| 04/04/2000 | US6045805 Oligosaccharide derived from an antigenic polysaccharide obtained from a pathogenic agent |
| 04/04/2000 | US6045802 Antitumor agents treating cancer |
| 04/04/2000 | US6045791 Culturing the harvested retinal pigment epithelial cells from donor tissue on a culture substrate to form a monolayer, transferring to a non-toxic flexible support, then transplanting to the subretinal space in eye |
| 04/04/2000 | CA2204739C Macrocyclic lactone compounds and their production process |
| 03/30/2000 | WO2000017374A1 Retroviral particles protected against complement mediated destruction |
| 03/30/2000 | WO2000017373A1 Recombinant celo virus and celo virus dna |
| 03/30/2000 | WO2000017371A1 Polynucleotide constructs and uses thereof |
| 03/30/2000 | WO2000017361A2 Interferon-epsilon |
| 03/30/2000 | WO2000017346A2 Hairpin hybridizer molecules for modulation of gene expression |
| 03/30/2000 | WO2000017326A1 Non-hematopoietic cells, including cardiomyocytes and skeletal muscle cells, derived from hematopoietic stem cells and methods of making and using them |
| 03/30/2000 | WO2000017325A1 Trophoblast cell preparations |
| 03/30/2000 | WO2000017321A2 Use of growth factors and hormones for expansion of mammalian cells and tissue engineering |
| 03/30/2000 | WO2000017217A1 Process of obtaining genistin-rich isoflavone composition |
| 03/30/2000 | WO2000016817A1 Dermal scaffold using neutralized chitosan sponge or neutralized chitosan/collagen mixed sponge |
| 03/30/2000 | WO2000016800A2 Methods of treating chronic pain |
| 03/30/2000 | WO2000016799A1 Methods of treating chronic pain |
| 03/30/2000 | WO2000016788A1 Method for successful early weaning of very young swine |
| 03/30/2000 | WO2000016787A1 Antler herb medicine fermented with chicken gizzard and a method for preparation thereof |
| 03/30/2000 | WO2000016786A2 Oxihumic acid and its use in the treatment of various conditions |
| 03/30/2000 | WO2000016785A2 Humic acid and its use in the treatment of various conditions |
| 03/30/2000 | WO2000016641A1 Interactions between genotype and diet in swine that prevent e coli associated intestinal disease |
| 03/30/2000 | WO2000009711A8 ISOLATED AND PURIFIED HUMAN SOLUBLE GUANYLYLCYCLASE α1/β1 (hsGCα1/β1) |
| 03/30/2000 | WO2000000186A8 Method of treating topical ailments |
| 03/30/2000 | WO1999063101A9 Transfected cells and methods for treating diabetes |
| 03/30/2000 | WO1999061066A9 Convection-enhanced delivery of aav vectors |
| 03/30/2000 | DE19844469A1 Production of an antimicrobial agent useful for pharmaceutical or disinfectant purposes comprises culturing a bacterium, washing the culture and heat treating the wash liquid |
| 03/30/2000 | DE19843521A1 Use of bile in the treatment of hyperacidity and pyrosis |
| 03/30/2000 | DE19831873A1 Process for therapeutic immuno-modulation comprises the use of cells with immuno-modulatory activity in an extra-corporeal circulation |
| 03/30/2000 | CA2345397A1 Trophoblast cell preparations |
| 03/30/2000 | CA2344399A1 Use of growth factors and hormones for expansion of mammalian cells and tissue engineering |
| 03/30/2000 | CA2343090A1 Retroviral particles protected against complement mediated destruction |
| 03/30/2000 | CA2343067A1 Hairpin hybridizer molecules for modulation of gene expression |
| 03/30/2000 | CA2342773A1 Interferon-epsilon |
| 03/30/2000 | CA2339866A1 Recombinant celo virus and celo virus dna |
| 03/29/2000 | EP0988862A2 Formulation for use in immunisation |
| 03/29/2000 | EP0988860A1 NKT CELL ACTIVATORS CONTAINING $g(a)-GLYCOSYLCERAMIDES |
| 03/29/2000 | EP0988390A1 Alternatively targeted adenovirus |
| 03/29/2000 | EP0988377A1 Zinc finger protein derivatives and methods therefor |
| 03/29/2000 | EP0988103A4 In-line gravity driven liquid filtration device useable to filter blood or blood products |
| 03/29/2000 | EP0988103A1 In-line gravity driven liquid filtration device useable to filter blood or blood products |
| 03/29/2000 | EP0988063A2 Process for reducing the concentration of viral and molecular pathogens in a biological material |
| 03/29/2000 | EP0988043A1 Method and product using sturgeon notochord for alleviating the symptoms of arthritis |
| 03/29/2000 | EP0987957A1 Method for administering viable microorganism composition for poultry |
| 03/29/2000 | CN1249000A Method for separating cells |
| 03/29/2000 | CN1248919A Immunotherapeutic agent for cancer containing nucleoidal component bacterium as active ingredient |
| 03/29/2000 | CN1248470A Chinese patent drug-Yibao for treating diabetes |
| 03/29/2000 | CN1248469A Powder medicine for treating hepatitis B |
| 03/29/2000 | CN1248468A Traditional Chinese medicine Sanfeng anti-cancer capsule for curing lung cancer and preparation process thereof |